Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers (Q34803360)

4 August 2017

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers (English)

1 reference

cost-effectiveness analysis

4 August 2017

1 reference

based on heuristic

inferred from title

breast cancer screening

1 reference

1 reference

Linlea Armstrong

2

0 references

Stuart Peacock

object named as

Stuart Peacock

9

0 references

author name string

Reka Pataky

1

1 reference

4 August 2017

Stephen Chia

3

1 reference

4 August 2017

Andrew J Coldman

4

1 reference

4 August 2017

Charmaine Kim-Sing

5

1 reference

4 August 2017

Barbara McGillivray

6

1 reference

4 August 2017

Jenna Scott

7

1 reference

4 August 2017

Christine M Wilson

8

1 reference

4 August 2017

language of work or name

English

0 references

publication date

10 July 2013

1 reference

4 August 2017

1 reference

4 August 2017

13

1 reference

4 August 2017

339

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-339

4 August 2017

0 references

cites work

The benefits and harms of breast cancer screening: an independent review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Meta-analysis of BRCA1 and BRCA2 penetrance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Can differences in breast cancer utilities explain disparities in breast cancer care?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Performance of screening mammography among women with and without a first-degree relative with breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Systematic overview of cost-utility assessments in oncology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Quality of life valuations of mammography screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-339

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Shorter hospital stays for breast cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3711845

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23837641

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-13-339

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference